Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02925585 · ClinicalTrials.gov registry record

Vaginal Tactile Imaging for Pelvic Floor Prolapse

A clinical trial, sponsored by Artann Laboratories.

Completed
Registry status
119
Enrollment target

NCT02925585 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 119 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02925585 has completed, sponsored by Artann Laboratories.

COMPLETED
Registry status
119 participants
Enrollment target

Study Summary

The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.

Interventions

  • OTHER Pre/post imaging

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2016-09
Est. Completion 2018-12

Sponsor

Artann Laboratories

14 total trials

What the Registry Record Tells You About NCT02925585

The ClinicalTrials.gov registry entry for NCT02925585 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artann Laboratories, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pre/post imaging is the first listed.

NCT02925585 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02925585 about?

NCT02925585 is a clinical study titled "Vaginal Tactile Imaging for Pelvic Floor Prolapse". The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.

What is the current status of trial NCT02925585?

This trial is currently completed. The enrollment target is 119 participants. The study started on 2016-09. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02925585?

The interventions under investigation include: Pre/post imaging (OTHER).

Who is sponsoring clinical trial NCT02925585?

This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.